Elevated maternal urine level of β-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of Down syndrome
Open Access
- 31 October 1999
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 181 (4) , 929-933
- https://doi.org/10.1016/s0002-9378(99)70327-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Combining β‐core fragment and total oestriol measurements to test for Down syndrome pregnanciesPrenatal Diagnosis, 1997
- Maternal serum screening for Down syndrome in the United States: A 1995 surveyAmerican Journal of Obstetrics and Gynecology, 1997
- SCREENING FOR DOWN SYNDROME PREGNANCY USING β-CORE FRAGMENT: PROSPECTIVE STUDYPrenatal Diagnosis, 1997
- Second‐trimester levels of maternal urinary gonadotropin peptide in down syndrome pregnancyPrenatal Diagnosis, 1995
- Urinary multiple marker screening for down's syndromePrenatal Diagnosis, 1995
- Choice of Serum Markers in Antenatal Screening for Down's SyndromeJournal of Medical Screening, 1994
- Maternal serum screening for fetal down syndrome in the United States: A 1992 surveyAmerican Journal of Obstetrics and Gynecology, 1993
- Predictive values, relative risks, and overall benefits of high and low maternal serum α-fetoprotein screening in singleton pregnancies: New epidemiologic dataAmerican Journal of Obstetrics and Gynecology, 1989
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalitiesAmerican Journal of Obstetrics and Gynecology, 1984